Clinical trial · Interventional
Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer
Acupuncture for Hot Flashes in Prostate Cancer Patients
NCT00244894CI-TRIAL-00027274terminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Acupuncture may help relieve hot flashes in patients with prostate cancer. PURPOSE: This clinical trial is studying how well acupuncture works in treating hot flashes in patients with prostate cancer who are undergoing androgen deprivation.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Fatigue | — | UNRESOLVED | — |
| Hot Flashes | — | UNRESOLVED | — |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| acupuncture therapy | Procedure | — | UNRESOLVED |
| fatigue assessment and management | Procedure | — | UNRESOLVED |
| hot flashes attenuation | Procedure | — | UNRESOLVED |
| management of therapy complications | Procedure | — | UNRESOLVED |
| quality-of-life assessment | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Reduced hot flash frequency and intensity as measured by hot flash score from hot flash diary at 4 weeks after initiation of study treatment
- timeFrame
- Weeks 4 after initiation of study treatment.
- measure
- Reduced hot flash frequency and intensity as measured by hot flash score from hot flash diary at 10 weeks after initiation of study treatment
- timeFrame
- 10 Weeks after initiation of study treatment.
- measure
- Reduced hot flash frequency and intensity as measured by hot flash score from hot flash diary at 16 weeks after initiation of study treatment
- timeFrame
- 16 Weeks after initiation of study treatment.
Secondary outcomes (5)
- measure
- Improved quality of life as measured by hot flash related-quality of life (HFR-QOL) and elements of short form health survey (SF-36) at 4 weeks after initiation of study treatment
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 120 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Confirmed diagnosis of prostate cancer * Hot flash score ≥ 4 per day * Prior or concurrent treatment with 1 of the following : * Bilateral orchiectomy * Gonadotropin releasing-hormone (GnRH) agonist or antagonist therapy * Antiandrogen therapy PATIENT CHARACTERISTICS: Performance status * Not specified Life expectancy * Not specified Hematopoietic * Not specified Hepatic * Not specified Renal * Not specified Other * No mental impairment PRIOR CONCURRENT THERAPY: Chemotherapy * No concurrent chemotherapy Endocrine therapy * See Disease Characteristics * More than 4 weeks since prior estrogen or progestational drugs Surgery * See Disease Characteristics * No prior placement of a pacemaker or other implantable electrical device Other * More than 4 weeks since prior gabapentin * No concurrent antidepressant drugs
References
Publications (0)
Data not yet available
No reference posted for this study.